Principal Financial Group Inc. Has $23.88 Million Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Principal Financial Group Inc. trimmed its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 5.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,584,850 shares of the company's stock after selling 203,856 shares during the quarter. Principal Financial Group Inc. owned 0.93% of LifeStance Health Group worth $23,875,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of LFST. Bank of New York Mellon Corp boosted its position in shares of LifeStance Health Group by 4.0% in the fourth quarter. Bank of New York Mellon Corp now owns 400,816 shares of the company's stock valued at $2,954,000 after acquiring an additional 15,365 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of LifeStance Health Group by 0.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,113,499 shares of the company's stock valued at $8,206,000 after acquiring an additional 9,046 shares during the period. AlphaQuest LLC acquired a new position in shares of LifeStance Health Group in the fourth quarter valued at $340,000. First Eagle Investment Management LLC raised its stake in shares of LifeStance Health Group by 182.8% in the fourth quarter. First Eagle Investment Management LLC now owns 785,666 shares of the company's stock valued at $5,790,000 after purchasing an additional 507,826 shares in the last quarter. Finally, Cibc World Markets Corp acquired a new position in shares of LifeStance Health Group in the fourth quarter valued at $96,000. 85.50% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on the company. UBS Group upgraded LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price for the company in a research note on Tuesday, May 27th. KeyCorp assumed coverage on LifeStance Health Group in a research note on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 target price for the company. Finally, Canaccord Genuity Group assumed coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They issued a "buy" rating and a $8.00 target price for the company. One research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, LifeStance Health Group currently has an average rating of "Moderate Buy" and a consensus price target of $8.50.

LifeStance Health Group Price Performance

NASDAQ:LFST traded up $0.02 on Wednesday, reaching $4.75. The stock had a trading volume of 1,580,882 shares, compared to its average volume of 1,673,460. The company has a market capitalization of $1.85 billion, a P/E ratio of -47.50 and a beta of 1.16. The stock has a fifty day moving average price of $5.57 and a 200-day moving average price of $6.73. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 1-year low of $4.61 and a 1-year high of $8.61.

Insider Buying and Selling at LifeStance Health Group

In other news, insider Ujjwal Ramtekkar sold 16,000 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $5.94, for a total transaction of $95,040.00. Following the completion of the sale, the insider owned 113,435 shares of the company's stock, valued at approximately $673,803.90. This trade represents a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 6.60% of the company's stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.